02

  • No Paxlovid benefit seen for long COVID

    Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.

  • Williams receives $18 million NIH grant

    Professor of psychiatry and behavioral health Leanne Williams will lead a project to define depression’s cognitive biotypes and create tools for clinicians to diagnose and treat patients.

  • Howard Chang awarded Lurie Prize

    The professor of dermatology and genetics was honored with the 2024 Lurie Prize for his studies into the role of long noncoding RNA in health and disease.

  • Myelination may drive drug addiction

    New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

  • Foretelling breast cancer

    In a finding that vastly expands the understanding of tumor evolution, researchers discover genetic biomarkers that can predict the breast cancer subtype a patient is likely to develop.

  • George Hahn dies at 98

    A personal tragedy spurred Hahn, who had escaped Nazi Europe as a child, to pursue a career seeking new therapies for cancer.

  • Sleep timing affects mental health

    In a new, large-scale study of sleep behavior, Stanford Medicine scientists found that night owls don’t really thrive late at night.

  • Speech impairment in Parkinson’s

    Most Parkinson’s disease patients struggle with speech problems. New research by Stanford Medicine scientists uncovers the brain connections that could be essential to preserving speech.

  • Garcia wins 2024 Passano Award

    Garcia was recognized for his research into the way molecules bind to one another and its implications for safer and more effective treatments.

  • Symposium tackles AI’s role in medicine

    Artificial intelligence experts discuss how to integrate trustworthy AI into health care, why multi-disciplinary collaboration is crucial and the potential for generative AI in research.


2024 ISSUE 1

Psychiatry’s new frontiers